IL13 and neoplasm: CSCs release galectin-3, growth differentiation factor 15 (GDF-15), interleukin-10 (IL-10), interleukin-13 (IL-13), prostaglandin E2 (PGE2), and transforming growth factor-beta (TGF-β), which are known to modulate the tumor niche.